FindTrial
Sign In

Use of blood parameters (Monocyte-to-HDL Cholesterol ratio) to assess the degree of Proteinuria (loss of protein in the urine) in patients with Pre-diabetes and Type 2 Diabetes Mellitus

Monocyte-to-HDL Cholesterol Ratio as a Marker of Proteinuria in Pre-Diabetes and Type 2 Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097671
Enrollment
140
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: Nil: Nil

Sponsors

KMC Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age more than or equal to 18 years 2) Patients who have HbA1c more than or equal to 5.6% OR a fasting glucose level of more than 126 mg/dl 3) Known diabetics/ pre-diabetics on treatment (lifestyle and/or medication) with good diabetic control, not meeting inclusion criteria 2.

Exclusion criteria

Exclusion criteria: 1) Patients who have other systemic diseases that may lead to proteinuria or impaired eGFR i.e a. Acute infections b. Chronic infections like HIV, Tb c. Malignancies d. Autoimmune disorders e. Severe hepatic dysfunction f. Congestive heart failure g. Acute kidney injury h. Uncontrolled hypertension (BP more than or equal to 140/90) 2) Type 1 diabetics 3) Patients in diabetic ketoacidosis or hyperosmolar nonketotic state

Design outcomes

Primary

MeasureTime frame
ProteinuriaTimepoint: End of study—

Secondary

MeasureTime frame
eGFR as a measure of renal functionTimepoint: End of study—

Countries

India

Contacts

Public ContactDr Shreya A Bhat

Kasturba Medical College Manipal

mm.prabhu@manipal.edu6362069834

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026